Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03314935
Title A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications

Advanced Solid Tumor

Therapies

INCB001158 + Paclitaxel

Cisplatin + Gemcitabine + INCB001158

Fluorouracil + INCB001158 + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA | BEL


No variant requirements are available.